Form 4 Tracker
Arcutis Biotherapeutics, Inc.
ARQT

45 insider filings · Latest: Sep 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 28, 2025May 28 7:47 PMMatsuda Masaru
Proposed Sale
1,800$13.78$24.8K—

View →

May 19, 2025May 19 7:54 PMEdwards Larry Todd
Proposed Sale
7,451$14.07$104.8K—

View →

May 8, 2025May 8 6:54 PMBurnett Patrick
Proposed Sale
3,871$13.59$52.6K—

View →

May 2, 2025May 2 8:24 PMWatanabe Todd Franklin
Proposed Sale
11,448$15.19$173.9K—

View →

May 2, 2025May 2 8:20 PMBurnett Patrick
Proposed Sale
2,597$15.19$39.4K—

View →

May 2, 2025May 2 8:20 PMMatsuda Masaru
Proposed Sale
5,030$15.20$76.5K—

View →

May 1, 2025May 1 8:21 PMWelgus Howard G.
Proposed Sale
10,000$14.64$146.4K—

View →

Apr 2, 2025Apr 2 8:18 PMTopper David Joseph
Proposed Sale
9,600$15.80$151.7K—

View →

Apr 1, 2025Apr 1 8:07 PMWelgus Howard G.
Proposed Sale
10,000$15.12$151.2K—

View →

Mar 25, 2025Mar 25 9:09 PMWatanabe Todd Franklin
Proposed Sale
2,171$17.56$38.1K—

View →

Mar 24, 2025Mar 24 8:20 PMWatanabe Todd Franklin
Proposed Sale
1,500$17.52$26.3K—

View →

Mar 17, 2025Mar 20 9:03 PMWatanabe Todd Franklin
Proposed Sale
1,200$17.61$21.1K—

View →

Mar 4, 2025Mar 14 8:19 PMBurnett Patrick
Proposed Sale
12,242$15.04$184.1K—

View →

Mar 4, 2025Mar 13 9:10 PMBurnett Patrick
Proposed Sale
49,161$14.98$736.4K—

View →

Mar 4, 2025Mar 4 9:47 PMBurnett Patrick
Proposed Sale
954$13.28$12.7K—

View →

Mar 4, 2025Mar 4 9:46 PMWatanabe Todd Franklin
Proposed Sale
4,135$13.28$54.9K—

View →

Mar 3, 2025Mar 3 10:39 PMWatanabe Todd Franklin
Proposed Sale
20,880$13.03$272.1K—

View →

Mar 3, 2025Mar 3 10:38 PMMatsuda Masaru
Proposed Sale
3,263$13.03$42.5K—

View →

Mar 3, 2025Mar 3 10:36 PMBurnett Patrick
Proposed Sale
2,819$13.03$36.7K—

View →

Mar 3, 2025Mar 3 9:50 PMWelgus Howard G.
Proposed Sale
10,000$13.00$130.0K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 15, 2026Sep 17 8:06 PMHoward G. WelgusDirector
Option Exercise
4,096$8.6318,032(D)

View →

Aug 27, 2026Aug 28 9:40 PMTerrie CurranDirector
Option Exercise
38,200$8.630(D)

View →

Aug 20, 2026Aug 24 8:19 PMTerrie CurranDirector
Option Exercise
1,072$7.5111,148(D)

View →

Aug 17, 2026Aug 19 8:57 PMHoward G. WelgusDirector
Option Exercise
4,096$8.6320,287(D)

View →

Aug 12, 2026Aug 14 12:06 AMPatrick BurnettReporting Person's title: EVP, Chief Medical Officer
Option Exercise
6,700$3.64128,750(D)

View →

Aug 11, 2026Aug 14 12:06 AMPatrick BurnettReporting Person's title: EVP, Chief Medical Officer
Option Exercise
8,300$3.64135,450(D)

View →

Jul 15, 2026Jul 17 8:07 PMChristopher PeetzDirector
Grant/Award
34,496$27.7813,010(D)

View →

Jul 15, 2026Jul 17 8:01 PMHoward G. WelgusDirector
Option Exercise
4,096$8.6322,542(D)

View →

Jun 15, 2026Jun 18 12:40 AMHoward G. WelgusDirector
Option Exercise
4,096$8.6324,797(D)

View →

Jun 5, 2026Jun 10 1:21 AMPatrick J HeronDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMSue-Jean LinDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMHoward G. WelgusDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMKeith R LeonardDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMTerrie CurranDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:21 AMAmit MunshiDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:20 AMHalley E GilbertDirector
Grant/Award
16,667$21.2316,667(D)

View →

Jun 5, 2026Jun 10 1:20 AMNeha KrishnamohanDirector
Grant/Award
16,667$21.2316,667(D)

View →

Mar 2, 2026Mar 4 9:17 PMKeith R LeonardDirector
Option Exercise
39,272$8.630(D)

View →

Feb 27, 2026Mar 4 1:43 AMLarry Todd EdwardsReporting Person's title: EVP, Chief Commercial Officer
Grant/Award
77,000$26.9777,000(D)

View →

Feb 27, 2026Mar 4 1:42 AMTodd WatanabeDirector, Reporting Person's title: President and Chief Executive Officer
Grant/Award
266,000$26.97266,000(D)

View →

Page 1 of 2

Next →